Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Aquestive Therapeutics, Inc. (AQST) had Receiveable Turnover of 0.73 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$13.02M |
|
$-31.86M |
|
$5.84M |
|
$7.18M |
|
$41.85M |
|
$-28.84M |
|
$-3.02M |
|
$-31.86M |
|
$-31.86M |
|
$-31.86M |
|
$-31.86M |
|
$-31.86M |
|
$-31.86M |
|
$-28.84M |
|
$-25.96M |
|
106.93M |
|
106.93M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$149.27M |
|
$3.89M |
|
$11.16M |
|
$160.43M |
|
$47.61M |
|
$27.52M |
|
$146.48M |
|
$194.09M |
|
$-33.66M |
|
$-33.66M |
|
$-33.66M |
|
122.04M |
|
| Cash Flow Statement Financials | |
$-52.43M |
|
$-0.56M |
|
$102.62M |
|
$71.55M |
|
$121.17M |
|
$49.62M |
|
$7.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.14 |
|
-- |
|
-- |
|
-4.48 |
|
-0.82 |
|
55.16% |
|
-221.58% |
|
-221.58% |
|
-- |
|
-244.79% |
|
-244.79% |
|
$-52.99M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.95 |
|
|
Receiveable Turnover |
0.73 |
122.83 |
|
94.65% |
|
94.65% |
|
-19.86% |
|
518.64% |
|
$-0.28 |
|
$-0.50 |
|
$-0.49 |
|